Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach
- PMID: 23855697
- PMCID: PMC3778759
- DOI: 10.1164/rccm.201302-0244LE
Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach
Comment on
-
Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.Am J Respir Crit Care Med. 2013 Jul 15;188(2):133-40. doi: 10.1164/rccm.201207-1204PP. Am J Respir Crit Care Med. 2013. PMID: 23306542 Review.
-
Steep barriers to overcome for successful application of stem cell treatment in patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2013 Jul 15;188(2):251-2. doi: 10.1164/rccm.201301-0072LE. Am J Respir Crit Care Med. 2013. PMID: 23855695 No abstract available.
-
Idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach.Am J Respir Crit Care Med. 2013 Jul 15;188(2):252-3. doi: 10.1164/rccm.201301-0192LE. Am J Respir Crit Care Med. 2013. PMID: 23855696 No abstract available.
References
-
- Toonkel RL, Hare JM, Matthay MA, Glassberg MK. Mesenchymal stem cells and idiopathic pulmonary fibrosis: potential for clinical testing. Am J Respir Crit Care Med. 2013:133–140. - PubMed
-
- Hare JM, Fishman JE, Gerstenblith G, Difede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON Randomized Trial. JAMA. 2012;308:2369–2379. - PMC - PubMed
-
- Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA. 2009;106:14022–14027. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
